|
Volumn 25, Issue 19, 2004, Pages 1761-1762
|
Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIARRHYTHMIC AGENT;
ANTIINFLAMMATORY AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
C REACTIVE PROTEIN;
CARVEDILOL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUCOCORTICOID;
INTERLEUKIN 6;
METHYLPREDNISOLONE;
ANTIINFLAMMATORY ACTIVITY;
CARDIOVERSION;
CLINICAL TRIAL;
CORTICOSTEROID THERAPY;
DRUG EFFECT;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HUMAN;
INFLAMMATION;
LETTER;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RECURRENT DISEASE;
STROKE;
THROMBOEMBOLISM;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS;
ATRIAL FIBRILLATION;
GLUCOCORTICOIDS;
HUMANS;
INTERLEUKIN-6;
METHYLPREDNISOLONE;
RECURRENCE;
THROMBOSIS;
|
EID: 4644257322
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ehj.2004.08.001 Document Type: Letter |
Times cited : (11)
|
References (0)
|